Cargando…
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
BACKGROUND: The treatment of patients with malignant brain tumors remains a major oncological problem. The median survival of patients with glioblastoma multiforme (GBM), the most malignant type, is only 15 months after initial diagnosis and even less after tumor recurrence. Improvements of standard...
Autores principales: | Geletneky, Karsten, Huesing, Johannes, Rommelaere, Jean, Schlehofer, Joerg R, Leuchs, Barbara, Dahm, Michael, Krebs, Ottheinz, von Knebel Doeberitz, Magnus, Huber, Bernard, Hajda, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425127/ https://www.ncbi.nlm.nih.gov/pubmed/22436661 http://dx.doi.org/10.1186/1471-2407-12-99 |
Ejemplares similares
-
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
por: Hajda, Jacek, et al.
Publicado: (2017) -
Parvoviruses PARV4 and PARV5 and Hepatitis C Virus
por: Fryer, Jacqueline F., et al.
Publicado: (2007) -
Parenteral Transmission of the Novel Human Parvovirus PARV4
por: Simmonds, Peter, et al.
Publicado: (2007) -
Paratuberculosis in Captive Scimitar-Horned Oryxes (Oryx dammah)
por: Pigoli, Claudio, et al.
Publicado: (2020) -
Uterine metastatic rhabdomyosarcoma in a scimitar-horned oryx (Oryx
dammah)
por: GO, Du-Min, et al.
Publicado: (2018)